66
DEAR MEMBERSHIP
This issue marks
the 10th publication of the Journal of the International Hemp Association. From
our modest 28 page first issue of five years ago, we have reported the science
behind the industrial and medical uses of Cannabis. The changes of the
past few years have been amazing, and our journal has grown in an attempt to
keep pace with these events.
A renaissance of industrial hemp
cultivation has occurred worldwide, including its re-establishment in the UK,
Germany, Canada, Austria, Italy, and Australia. Progress in the medical use of Cannabis
has led to an increase in research that may well yield new Cannabis
medicines. Recent reports suggesting that pharmacological research and clinical
trials with Cannabis be pursued have been published in the US by the
National Institute of Health, as well as in Canada, Germany, Australia, New
Zealand and the UK's House of Lords. In February, the Institute on Medicine of
the US National Academy of Sciences is also due to release a comprehensive
report on the subject (see JIHA, June 1998: 36-39). Clinical trials will
be undertaken in the UK in 1999 with the involvement of the Royal Pharmaceutical
Society, and Prince Charles has stated his belief that Cannabis could be
effective for multiple sclerosis patients.
The IHA/VIR Cannabis Germplasm
Preservation Project (CGPP) requires an additional year to complete accession
reproductions, plus a following year to grow and characterize the entire
collection. It seems ironic that a small sector of modern agriculture is
rediscovering the utility of this ancient ally, at the same time that the
germplasm required to help fuel this rediscovery is slowly, but surely
vanishing. Both industrial and medical varieties are threatened by pressure from
misdirected anti-drug zealots and a lack of concern from mainstream agriculture.
Many local landraces have been eradicated within their native ranges. From where
will new and improved varieties come, if viable Cannabis collections are
not maintained by genebanks like the Vavilov Institute? No one can know the
traits that future breeders will require for plant improvement programs. As
stewards of this precious germplasm, its preservation for our children's
children is our responsibility. The Cannabis industry must become
motivated, through either compassion or self-interest, to mobilize the necessary
resources to conserve our past breeding achievements and this fine example of
nature’s untapped diversity.
A concerted effort has recently been
made to canvas the Cannabis community for both public and private grants
to support the CGPP, but we are unable to fulfill our scientific commitments
until this funding is forthcoming. In the case of our efforts to preserve Cannabis
germplasm, a relatively small amount of money can save an irreplaceable resource
that belongs to the whole world. Cannabis is a neglected crop with a
promising future of, as yet, unrealized uses.
The current interview with Michael
Karus, and two articles from his nova-Institute, illustrate how science has
helped shift the Cannabis information balance from fear to insight and
how these researchers strive to present data that will help establish parameters
for further development of Cannabis as an industrial crop. The first
nova-Institute article (page 96) clearly shows that the larger the quantity of
industrial hemp one consumes, the farther one departs from a psychoactive
effect. This results from the high ratio of CBD to THC in industrial hemp and
the slow rate of assimilation of its negligible THC content. The second nova
article (page 102) places the question of tolerance for THC in hemp food
products on a scientific basis. Its rationale may be overly cautious, but these
results are carefully derived and should serve as a sound basis for policy
makers.
The heated seed oil article of the
June issue generated considerable reader commentary. We present herein a
rebuttal to that article, and a reply from the primary researcher, in an effort
to further inform our readers.
The restructuring of Hempworld,
Hemp Magazine and Commercial Hemp comes as a shock, but no
surprise. We fully appreciate the difficulties involved with keeping a journal
alive, and we wish our colleagues success in their search for publishing
solutions. Thanks to all of our members for your continuing support, and to Carl
Olsen for maintaining the JIHA web presence.
We hope that each issue of the JIHA
improves upon the last, and will try to maintain this trend in the future. To
accomplish our goal, your input is needed in the form of articles, reports,
local and national roundups, and hemp product donations for the Cannabis
Edu-pack. We encourage article contributors to submit manuscripts as early as
possible (to help avoid late journals), and appeal to readers for their
nomination of any library appropriate as a JIHA subscriber. It would also
help us significantly if members would pay their dues at the beginning of each
year, rather than waiting until June. Finally, the IHA operates from a small
office in Amsterdam, and current members are welcome to contact us for a visit
(by appointment only). If available, we will be happy to show our library and
ever-growing collection of hemp articles.
Robert Clarke Projects Manager |
Janet Erisman Treasurer |
David Pate Secretary |
David Watson Chairman |
Hayo van der Werf Editor-in-Chief |